This is specially observed when a new compound enters animal testing. The SE of animals in experimentation is becoming dearer, due to limitations such as high costs involved in breeding and acquisition of animals, due to the complexity of procedures involved in the in vivo testing, and several other ethical issues and legal issues associated with it. Moreover the traditional biochemical assays also posses many limitations. To counteract these issues there has been a paradigm shift towards the use of cell-based assays.
The consumables formed the largest product segment of the total cell-based assays market in 2013, which includes assay kits and reagents, microscopes and cell lines. The largest contribution of consumables was attributed to the large volume market of reagents and assay kits; where most of the innovation is taking place. Drug discovery was the most prominent application of cell- based assays. Within drug discovery, lead identification and optimization accounted for the largest share in 2013. With respect to end users, the pharmaceutical and biotechnology companies commanded the largest share in 2013.
These industries are focusing on screening extensive libraries of compounds that could become leads for potential drug candidates. The screening process has helped the pharmaceutical impasses to run more cost and time efficient methods. For accurate results, the low cost label-free technology in cell based assays has emerged as a momentous technology that has been driving the growth of cell-based assay market. With the advancement in the cell stem cell culture, induced plenteous stem cells will be emerging in near future.
With the increasing demand of emergent AD cell-based assay, it is estimated to be the fastest growing technology in the next five years. North America accounted for the largest share of the global cell-based assay market in 2013. The presence of a large number of market players along with government ending for drug discovery and increasing number of public-private partnerships are the factors driving the North American cell-based assay market. Countries such as India and China serve as new revenue pockets for the cell-based assay market.
Healthcare reforms, government initiatives, growing awareness and increasing investments in drug discovery are encouraging the rising acceptance and adoption of the cell-based assay technology in these regions. The emerging countries in Asia such as China and India will register high growth in the coming years; this can be attributed to the low development costs offered by these nations. Moreover, clinical Cell-based Assays Market by Product report – Global Forecast to 2018 By demolishing in these nations.
The grey areas while estimating the market size was the overlapping nature of the products and technology while segregating them based on evaluation of endpoints involved. As there is a thin line between products and technology used, both were included while estimating the patient monitoring market. From an insight perspective, this research report focuses on the qualitative data, market size, share, growth of various segments and sub-segments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats).
The report also offers market shares, sizes, and related growth of various segments in the industry. It also focuses on the emerging and high-growth segments of cell-based assay market, high-growth regions, and the initiatives of respective governments. The competitive landscape covers the growth strategies adopted by industry players in the last three years. The company profiles comprise the basic views on the key players in the cell-based assay market, product portfolios, placements, and strategies adopted by market players to maintain and increase their market shares in the near future.
The above mentioned market research data, current market size, and forecast of future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
